Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for:

OBESITY-BUSINESS/
RTX15EET
November 15, 2013
A Novo Nordisk employee controls a kettle at an insulin production in a plant in Kalundborg November...
Kalundborg, Denmark
A Novo Nordisk employee controls a kettle at an insulin production in a plant in Kalundborg
A Novo Nordisk employee controls a kettle at an insulin production in a plant in Kalundborg November 4, 2013. Picture taken November 4, 2013. Novo Nordisk's Kalundborg factory, 100 km west of Copenhagen, makes half the planet's insulin for diabetics, putting it on a list of global sites the United States sees as vital to its interests, according to a WikiLeaks cable in 2010. Soaring diabetes rates, driven by increasing obesity, have fuelled profits at the Danish company for two decades. But now the company wants to tackle obesity head on by launching a treatment specifically to help patients lose weight. To match Insight OBESITY-BUSINESS/
REUTERS/Fabian Bimmer (DENMARK - Tags: BUSINESS HEALTH)
Sort by
Display
Items per page
Page
of 1